pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Intently. Coadministration of CYP3A4 inducers may perhaps lessen sufentanil amounts and efficacy, quite possibly precipitating withdrawal syndrome in sufferers who may have